News and Announcements
Kazia Therapeutics features in multiple leading Australian publications
- Published April 19, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- Kazia Therapeutics (ASX: KZA) has recently appeared across multiple leading Australian financial publications and guest speaker at a Brisbane investor event.
- Media mentions include small-cap publication, Stockhead, nabtrade and investment newsletter, the Switzer Report
- Kazia CEO James Garner also presented at the Wholesale Investor Emergence event providing an update on Kazia’s lead programs and trials.
Kazia Therapeutics (ASX: KZA) has recently appeared across multiple leading Australian financial publications as well as presenting at the recent Wholesale Investor Emergence event.
CEO James Garner featured in small-cap publication, Stockhead, in regards to a bid to form an integrated approach for new options for cancer patients following Bill Shorten’s $2.3 billion cancer funding pledge.
Kazia has also been featured by financial journalist James Dunn as a leading ASX cancer stock to watch in both nabtrade and investment newsletter, the Switzer Report
Kazia CEO James Garner also presented at the Wholesale Investor Emergence event in Brisbane, detailing Kazia’s expected multiple data read-outs from its international human trials during calendar 2019 and an update on Kazia’s lead program, GDC-0084 to target glioblastoma.
About Kazia Therapeutics Limited (ASX: KZA)
Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA) is developing cancer treatments for areas which there is a high unmet medical need. Our lead program, GDC-0084, a drug to treat glioblastoma multiforme, the most aggressive brain cancer, has completed phase 1 human trials with strong safety and early efficacy signals. It is currently being prepared for phase 2 human trials.
Company Updates
Forget Startups: Why Magnetic Alliance is Betting on “Boring” Mid-Market Turnarounds
While Australia’s venture capital scene spent years chasing unprofitable tech startups and speculative high-growth plays, Mark Lim was quietly taking a radically different path. The Managing Partner of Magnetic Alliance Capital sees the nation’s richest investment opportunities hiding in plain sight: inside thousands of unglamorous, profitable, but operationally sluggish mid-market businesses. Speaking on Wholesale Investor’s […]
The asset class where the market has no vote
Litigation funding returns are decided in a courtroom, not a cycle. Knightsbridge’s Head of Capital is careful to call that a different risk rather than a lower one, and his answer to it is spread, not concentration. Most alternative assets still answer to something. Property answers to rates. Private credit answers to defaults. Even the […]
The listing fee vendors pay whether the house sells or not
Australia’s property portals collect more than $2 billion a year while national listings sit flat. An Australian-built AI platform is targeting the economics, not just the interface. An Australian vendor listing a home pays a vendor-paid advertising fee on top of agency commission. Rama Dwarapudi, Founder and Chief Executive Officer of RealSearch, puts a typical […]
Backed By Leading Investment Groups and Family Offices
